Invited reviewCherry-picked ligands at histamine receptor subtypes

- H1-R4Rs signaling pathways are discussed.
- Selected ligands representing key steps in drug development are provided.
- SARs of most innovative and/or most important ligands are presented.
- Pharmacological profiles of H1-H4R ligands are highlighted.
- Selection criteria for optimal compound use in experimental set-up are discussed.

Histamine, a biogenic amine, is considered as a principle mediator of multiple physiological effects through binding to its H1, H2, H3, and H4 receptors (H1-H4Rs). Currently, the HRs have gained attention as important targets for the treatment of several diseases and disorders ranging from allergy to Alzheimer's disease and immune deficiency. Accordingly, medicinal chemistry studies exploring histamine-like molecules and their physicochemical properties by binding and interacting with the four HRs has led to the development of a diversity of agonists and antagonists that display selectivity for each HR subtype. An overview on H1-R4Rs and developed ligands representing some key steps in development is provided here combined with a short description of structure-activity relationships for each class. Main chemical diversities, pharmacophores, and pharmacological profiles of most innovative H1-H4R agonists and antagonists are highlighted. Therefore, this overview should support the rational choice for the optimal ligand selection based on affinity, selectivity and efficacy data in biochemical and pharmacological studies.This article is part of the Special Issue entitled 'Histamine Receptors'.